{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:11:42Z","timestamp":1762866702921},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NCI R21","award":["CA179443"],"award-info":[{"award-number":["CA179443"]}]},{"name":"NCI P50","award":["CA083636"],"award-info":[{"award-number":["CA083636"]}]},{"name":"NCI U01","award":["CA152637"],"award-info":[{"award-number":["CA152637"]}]},{"DOI":"10.13039\/100000048","name":"ACS","doi-asserted-by":"publisher","award":["SIOP-06-258-COUN"],"award-info":[{"award-number":["SIOP-06-258-COUN"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007477","name":"Canary Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ygyno.2015.08.024","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T01:59:04Z","timestamp":1441331944000},"page":"253-260","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Identifying post-menopausal women at elevated risk for epithelial ovarian cancer"],"prefix":"10.1016","volume":"139","author":[{"given":"Nicole","family":"Urban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Janes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth Y.","family":"Karlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine D.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles W.","family":"Drescher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn E.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie R.","family":"Palomares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Wactawski-Wende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary J.","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randal D.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher I.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garnet L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2015.08.024_bb0005","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ygyno.2009.10.087","article-title":"Use of a symptom index, CA125, and HE4 to predict ovarian cancer","volume":"116","author":"Andersen","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.08.024_bb0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molonc.2009.02.001","article-title":"The contribution of BRCA1 and BRCA2 to ovarian cancer","volume":"3","author":"Ramus","year":"2009","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2015.08.024_bb0015","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risk of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ygyno.2015.08.024_bb0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2015.08.024_bb0025","series-title":"Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to Update the US Preventive Services Task Force Recommendation. Rockville (MD)","author":"Nelson","year":"2013"},{"issue":"4","key":"10.1016\/j.ygyno.2015.08.024_bb0035","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/GCO.0b013e32821642d1","article-title":"Elective oophorectomy in the gynecological patient: when is it desirable?","volume":"19","author":"Parker","year":"2007","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.08.024_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic salpingectomy: uptake, risks and complications of a regional initiative for ovarian cancer prevention","author":"McAlpine","year":"2014","journal-title":"Am. J. Obstet Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.08.024_bb0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2009.01.013","article-title":"Precursors to pelvic serous carcinoma and their clinical implications","volume":"113","author":"Folkins","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2015.08.024_bb0050","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/humrep\/der274","article-title":"The post-reproductive fallopian tube: better removed?","volume":"26","author":"Dietl","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ygyno.2015.08.024_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2013.03.023","article-title":"Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: Primum non nocere","author":"Morelli","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.08.024_bb0060","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ygyno.2013.04.021","article-title":"Opportunistic salpingectomy for women at low risk for development of ovarian carcinoma: the time has come","volume":"129","author":"Gilks","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.08.024_bb0065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/AOG.0b013e3181ec5fc1","article-title":"Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer","volume":"116","author":"Berek","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"18","key":"10.1016\/j.ygyno.2015.08.024_bb0070","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/jnci\/dji281","article-title":"Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families","volume":"97","author":"Kauff","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2015.08.024_bb0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.bjc.6604830","article-title":"Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation","volume":"100","author":"Metcalfe","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2015.08.024_bb0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jnci\/djp438","article-title":"Assessing lead time of selected ovarian cancer biomarkers: a nested case\u2013control study","volume":"102","author":"Anderson","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.ygyno.2015.08.024_bb0085","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2006.06.7884","article-title":"Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer","volume":"25","author":"Hermsen","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.08.024_bb0090","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2012.07.106","article-title":"Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass","volume":"127","author":"Karlsen","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2015.08.024_bb0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"22","key":"10.1016\/j.ygyno.2015.08.024_bb0100","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ygyno.2015.08.024_bb0105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/1940-6207.CAPR-10-0195","article-title":"Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens","volume":"4","author":"Cramer","year":"2011","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"3","key":"10.1016\/j.ygyno.2015.08.024_bb0110","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1158\/1940-6207.CAPR-10-0193","article-title":"For the PLCO Project Team. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer","volume":"4","author":"Zhu","year":"2011","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"21","key":"10.1016\/j.ygyno.2015.08.024_bb0115","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/jnci\/djr359","article-title":"Potential role of HE4 in multimodal screening for epithelial ovarian cancer","volume":"103","author":"Urban","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ygyno.2015.08.024_bb0120","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/AOG.0b013e318212fcb7","article-title":"Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy","volume":"117","author":"Vitonis","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.ygyno.2015.08.024_bb0125","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/aje\/kwr446","article-title":"Hormone therapy and different ovarian cancers: a national cohort study","volume":"175","author":"Morch","year":"2012","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.08.024_bb0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/13697137.2012.663818","article-title":"Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy \u2014 a nationwide study","volume":"16","author":"Koskela-Niska","year":"2013","journal-title":"Climacteric"},{"issue":"7","key":"10.1016\/j.ygyno.2015.08.024_bb0135","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/ijc.28167","article-title":"Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer\u2014a population-based case control study from Finland","volume":"133","author":"Koskela-Niska","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"9 Suppl.","key":"10.1016\/j.ygyno.2015.08.024_bb0140","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1047-2797(03)00043-7","article-title":"Implementation of the Women's Health Initiative Study Design","volume":"13","author":"Anderson","year":"2003","journal-title":"Ann. Epidemiol."},{"issue":"9 Suppl.","key":"10.1016\/j.ygyno.2015.08.024_bb0145","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S1047-2797(03)00048-6","article-title":"Outcomes ascertainment and adjudication methods in the Women's Health Initiative","volume":"13","author":"Curb","year":"2003","journal-title":"Ann. Epidemiol."},{"issue":"4","key":"10.1016\/j.ygyno.2015.08.024_bb0150","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10552-013-0145-9","article-title":"Epidemiologic features of borderline ovarian tumors in California: a population-based study","volume":"24","author":"Morris","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.ygyno.2015.08.024_bb0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00004347-199304000-00006","article-title":"The behavior of serous tumors of low malignant potential: are they ever malignant?","volume":"12","author":"Kurman","year":"1993","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.08.024_bb0160","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0090-8258(92)90099-5","article-title":"Long-term follow-up of serous ovarian tumors of low malignant potential","volume":"47","author":"Leake","year":"1992","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2015.08.024_bb0165","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/cncr.20080","article-title":"Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis","volume":"100","author":"Sherman","year":"2004","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2015.08.024_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biostatistics\/4.1.27","article-title":"A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker","volume":"4","author":"McIntosh","year":"2003","journal-title":"Biostatistics"},{"issue":"2","key":"10.1016\/j.ygyno.2015.08.024_bb0175","first-page":"159","article-title":"Generating longitudinal screening algorithms using novel biomarkers for disease","volume":"11","author":"McIntosh","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"11","key":"10.1016\/j.ygyno.2015.08.024_bb0180","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1158\/1055-9965.EPI-12-0616","article-title":"Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer","volume":"21","author":"Urban","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"6","key":"10.1016\/j.ygyno.2015.08.024_bb0185","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1200\/JCO.2012.43.2757","article-title":"Declining second primary ovarian cancer after first primary breast cancer","volume":"31","author":"Schonfeld","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2015.08.024_bb0190","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/ijc.28537","article-title":"The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer\u2014a population-based data linkage study","volume":"134","author":"Obermair","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.08.024_bb0195","author":"SEER Cancer Statistics Review"},{"issue":"5","key":"10.1016\/j.ygyno.2015.08.024_bb0200","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1634\/theoncologist.1-5-326","article-title":"Prophylactic oophorectomy: reducing the U.S. Death rate from epithelial ovarian cancer. A continuing debate","volume":"1","author":"Piver","year":"1996","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ygyno.2015.08.024_bb0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1200\/JCO.2011.39.7638","article-title":"Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule","volume":"31","author":"Rosenthal","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2015.08.024_bb0210","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/1055-9965.EPI-14-1128","article-title":"Population distribution of lifetime risk of ovarian cancer in the United States","volume":"24","author":"Pearce","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.ygyno.2015.08.024_bb0215","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","article-title":"Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy","volume":"129","author":"Powell","year":"2013","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:15:13Z","timestamp":1599524113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815301153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0090825815301153"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.08.024","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying post-menopausal women at elevated risk for epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}